Daito Pharmaceutical Ratios and Metrics

Market cap in millions JPY. Fiscal year is June - May.

Millions JPY. Fiscal year is Jun - May.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 26, 2026	May '25 May 31, 2025	May '24 May 31, 2024	May '23 May 31, 2023	May '22 May 31, 2022	May '21 May 31, 2021
Market Capitalization	42,842	29,536	34,043	33,086	37,154	44,980
Market Cap Growth	36.66%	-13.24%	2.89%	-10.95%	-17.40%	-21.02%
Enterprise Value	51,645	37,736	37,799	34,956	37,065	46,116
Last Close Price	1469.00	969.83	1058.51	967.02	1072.91	1314.78
PE Ratio	19.77	15.48	10.33	9.19	7.96	10.59
Forward PE	18.42	15.15	8.98	9.39	8.00	10.05
PS Ratio	0.84	0.58	0.73	0.73	0.86	0.92
PB Ratio	0.82	0.57	0.65	0.65	0.78	1.07
P/TBV Ratio	0.84	0.57	0.66	0.66	0.79	1.09
P/OCF Ratio	4.56	5.01	6.57	7.96	8.50	8.68
EV/Sales Ratio	1.01	0.75	0.81	0.78	0.85	0.95
EV/EBITDA Ratio	7.11	5.43	5.00	3.85	3.75	5.08
EV/EBIT Ratio	17.80	14.40	9.71	6.71	5.64	7.80
Debt / Equity Ratio	0.21	0.23	0.17	0.10	0.07	0.08
Debt / EBITDA Ratio	1.54	1.71	1.15	0.55	0.35	0.37
Net Debt / Equity Ratio	0.17	0.19	0.12	0.03	-0.02	0
Net Debt / EBITDA Ratio	1.23	1.39	0.79	0.15	-0.09	0.00
Net Debt / FCF Ratio	1.62	-10.85	-5.77	-1.00	3.63	-0.02
Asset Turnover	0.65	0.65	0.63	0.67	0.71	0.87
Inventory Turnover	2.16	2.14	1.89	1.98	1.97	2.72
Quick Ratio	1.26	1.32	1.05	1.38	1.46	1.26
Current Ratio	2.39	2.45	2.24	2.64	2.70	2.52
Return on Equity (ROE)	4.35%	3.38%	6.16%	7.15%	10.33%	10.55%
Return on Assets (ROA)	2.22%	2.10%	3.28%	4.81%	6.69%	6.60%
Return on Invested Capital (ROIC)	3.52%	2.61%	5.31%	7.31%	10.20%	10.62%
Return on Capital Employed (ROCE)	4.60%	4.30%	6.60%	9.50%	12.90%	13.20%
Earnings Yield	5.21%	6.46%	9.68%	10.88%	12.56%	9.44%
FCF Yield	12.63%	-3.02%	-3.05%	-4.08%	-0.69%	-2.53%
Dividend Yield	2.72%	3.61%	2.83%	2.82%	2.12%	1.59%
Payout Ratio	47.51%	52.31%	27.53%	25.86%	14.14%	15.50%
Buyback Yield / Dilution	2.67%	3.06%	0.86%	-3.38%	-1.94%	-6.42%
Total Shareholder Return	5.40%	6.67%	3.70%	-0.56%	0.18%	-4.83%

Updated Nov 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.